Prime Medicine Inc.
PRME | NASDAQ
$3.19
+$0.07 (+2.24%)
At close: Sep 21, 2026, 4:00 PM ET
$3.22
+$0.03 (+0.94%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.57 | -1.77 | -4.07 | -12.72 | -7.99 | -291.10 |
PEG Ratio | 0.14 | 0.07 | -0.08 | 0.53 | 0 | -3.60 |
PS Ratio | 111.44 | 116.10 | n/a | n/a | n/a | 282.41 |
PB Ratio | 4.27 | 2.26 | 6.06 | 5.71 | 6.14 | 43.96 |
P/FCF Ratio | -3.09 | -2.66 | -4.63 | -12.21 | -38.49 | -237.97 |
P/OCF Ratio | -3.18 | -2.82 | -4.87 | -13.70 | -43.17 | -265.40 |
OCF/S Ratio | -3.51K | -4.12K | n/a | n/a | n/a | -106.41 |
Debt / Equity Ratio | 0.96 | 0.27 | 0.10 | 0.09 | 0.04 | n/a |
Quick Ratio | 4.84 | 5.58 | 2.53 | 11.10 | 4.67 | 2.75 |
Current Ratio | 4.84 | 5.58 | 2.53 | 11.10 | 4.67 | 2.75 |
Asset Turnover | 0.01 | 0.01 | n/a | n/a | n/a | 0.10 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -166.41% | -127.90% | -148.89% | -38.52% | -69.03% | -10.19% |
Return on Assets | -58.69% | -65.84% | -102.21% | -33.81% | -54.78% | -6.22% |
Return on Invested Capital | -66.48% | -76.94% | -139.40% | -33.49% | -33.53% | -2.64% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -58.05% | 100% | n/a | n/a | n/a | 42.80% |
Net Profit Margin | -4.34K% | -6.57K% | n/a | n/a | n/a | -65.45% |
Pretax Profit Margin | -4.34K% | -6.57K% | n/a | n/a | n/a | -29.62% |
Operating Profit Margin | -4.5K% | -6.79K% | n/a | n/a | n/a | -17.89% |
FCF Margin | -3.61K% | -4.36K% | n/a | n/a | n/a | -118.68% |
EBITDA Margin | -4.23K% | -6.36K% | n/a | n/a | n/a | -17.06% |
Add to Watchlist
Select watchlists to add or remove PRME